Adding selectivity to antimicrobial peptides:: Rational design of a multidomain peptide against Pseudomonas spp.

被引:122
作者
Eckert, R
Qi, FX
Yarbrough, DK
He, J
Anderson, MH
Shi, WY
机构
[1] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[3] C3 Jian Inc, Sequim, WA 98382 USA
关键词
D O I
10.1128/AAC.50.4.1480-1488.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Currently available antimicrobials exhibit broad killing with regard to bacterial genera and species. Indiscriminate killing of microbes by these conventional antibiotics can disrupt the ecological balance of the indigenous microbial flora, often resulting in negative clinical consequences. Species-specific antimicrobials capable of precisely targeting pathogenic bacteria without damaging benign microorganisms provide a means of avoiding this problem. In this communication, we report the successful creation of the first synthetic, target-specific antimicrobial peptide, G10KHc, via addition of a rationally designed Pseudomonas-specific targeting moiety (KH) to a generally killing peptide (novispirin GIO). The resulting chimeric peptide showed enhanced bactericidal activity and faster killing kinetics against Pseudomonas spp. than GIO alone. The enhanced killing activities are due to increased binding and penetration of the outer membrane of Pseudomonas sp. cells. These properties were not observed in tests of untargeted bacterial species, and this specificity allowed G10KHc to selectively eliminate Pseudomonas spp. from mixed cultures. This work lays a foundation for generating target-specific "smart" antimicrobials to complement currently available conventional antibiotics.
引用
收藏
页码:1480 / 1488
页数:9
相关论文
共 43 条
[1]   Binding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia -: art. no. 18 [J].
Albrecht, MT ;
Wang, W ;
Shamova, O ;
Lehrer, RI ;
Schiller, NL .
RESPIRATORY RESEARCH, 2002, 3 (01)
[2]   PSEUDOMONAS-MENDOCINA, AN ENVIRONMENTAL BACTERIUM ISOLATED FROM A PATIENT WITH HUMAN INFECTIVE ENDOCARDITIS [J].
ARAGONE, MD ;
MAURIZI, DM ;
CLARA, LO ;
ESTRADA, JLN ;
ASCIONE, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (06) :1583-1584
[3]   Innate immunity and the normal microflora [J].
Boman, HG .
IMMUNOLOGICAL REVIEWS, 2000, 173 :5-16
[4]   Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic [J].
Breukink, E ;
Wiedemann, I ;
van Kraaij, C ;
Kuipers, OP ;
Sahl, HG ;
de Kruijff, B .
SCIENCE, 1999, 286 (5448) :2361-2364
[5]   Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? [J].
Brogden, KA .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) :238-250
[6]   Antimicrobial peptides in animals and their role in host defences [J].
Brogden, KA ;
Ackermann, M ;
McCray, PB ;
Tack, BF .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 (05) :465-478
[7]  
Chen P, 1999, APPL ENVIRON MICROB, V65, P1356
[8]  
Diamond Gill, 2001, Biologist (London), V48, P209
[9]   A bacteriocin-like peptide induces bacteriocin synthesis in Lactobacillus plantarum C11 [J].
Diep, DB ;
Havarstein, LS ;
Nes, IF .
MOLECULAR MICROBIOLOGY, 1995, 18 (04) :631-639
[10]   STAPHYLOCOCCAL COAGULASE - MODE OF ACTION AND ANTIGENICITY [J].
DUTHIE, ES ;
LORENZ, LL .
JOURNAL OF GENERAL MICROBIOLOGY, 1952, 6 (1-2) :95-107